COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Contents
- Metabolic syndrome and risk of colorectal adenoma and colorectal cancer: A meta-analysis
- Biological and functional properties of vine leaves
- Impact of care group participation on nutrition knowledge, behaviour and practices
- Microwave-assisted extraction optimization and conventional extraction of phenolic compounds from coriander leaves: UHPLC characterization and antioxidant activity
- Nutritional Quality Assessment and Dietary Diversity of Food in Collective Catering: A Study in Al Hoceima Province, Morocco
- Cyclodextrins for UV Protection in Food, Beverages, and Agricultural Products: A Comprehensive Review
- Development of an Edible Film - Lined Tetra Pak: Accelerated Shelf Life of Extra Virgin Olive Oil
- Hepatorenal and Cerebral Toxicity Induced by Consumption of Cow Meat Singed with Scrap Tyres: An Experimental Study in a Rat Model
- Mold Chitosan production using Ficus microcarpa fruit
You may also start an advanced similarity search for this article.
NAJFNR is licensed under